Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
[WEBINAR] Molecular bioanalysis considerations along the drug development journey 11 days 20 hours 31 mins 7 secs REGISTER NOW!

Echo® MS System for high-throughput analysis

2 Nov 2020
Written by SCIEX
Drug development MS (LC–MS/MS, HRMS, IMS)

This presentation outlines the analytical challenges in MS-based screening, acoustic ejection mass spectrometry technology and the application of the Echo® MS System beyond drug discovery and development.

 

SPOTLIGHT-Echo-MS press-release slides-Chang-min


This content was supplied by SCIEX. 

Top content

  • Waters launches the Xevo TQ Absolute XR at ASMS 2025
  • How can diagnostic laboratories accelerate the clinical adoption of allogeneic cell therapies?
  • Why NGS ELN deployments fail

Related tags

LC-MS sciex
Previous article Next article

Related articles

2 JUN 2020 DRUG DEVELOPMENT

New Echo® MS system announced by SCIEX at ASMS 2020 Reboot

27 JUN 2013 CHROMATOGRAPHY

New LC–MS system combines three mass analyzers for improved selectivity and sensitivity

22 SEP 2017 SAMPLE PREPARATION

Sciex: SelexION® differential mobility spectrometry

11 FEB 2014 GENERAL INTEREST

Variability of the IS revealed ionization enhancement by bile acid in mouse plasma

11 OCT 2012 COLLABORATIONS AND MERGERS

2012 White Paper on Recent Issues in Bioanalysis and Alignment of Multiple Guidelines

6 OCT 2016 NEWS

Researchers use Mass Spec to find new biomarker for pancreatic cancer

  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
Contact
Contact Us
Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone